心血管疾病及其与巨细胞动脉炎中脂质参数和内皮功能障碍的关联
Philipp Jud1, Franz Hafner2, Andreas Meinitzer3
1Internal Medicine, Medizinische Universitat Graz, Graz, Austria philipp.jud@medunigraz.at.
RMD open
|September 1, 2023
概括
巨细胞动脉炎 (GCA) 患者面临心血管疾病风险升高,原因是脂质管理不良和他类药物使用不足. 改进的预防策略对于减少这一群体心血管事件至关重要.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 血管医学 血管医学
背景情况:
- 巨细胞动脉炎 (GCA) 与内皮功能障碍和脂质代谢异常有关.
- 心血管疾病 (CVD) 是GCA患者的一个重大问题,但预防策略需要优化.
研究的目的:
- 评估内皮功能障碍,脂质新陈代谢以及GCA患者心血管疾病的患病率和发展.
- 评估与对照组相比,GCA患者的心血管风险因素和结果.
主要方法:
- 一项队列研究涉及138名GCA患者和100名对照人群,在2012年进行评估,并在2020年进行后续调查.
- 测量包括心血管疾病的流行,脂质概况,内心介质厚度,动脉硬度和不对称/对称的二甲基氨基.
- 心血管事件,死亡率和复发数据通过图表审查收集.
主要成果:
- 与对照组相比,GCA患者表现出较高的冠状动脉和脊椎动脉疾病流行率以及总胆固醇,LDL,HDL和其他脂蛋白水平的升高.
- 在随访期间,GCA患者较少达到目标的LDL水平,并经历了更多新的心血管事件.
- 立方体治疗与减少的不对称二甲基氨基,单细胞和C反应蛋白相关;GCA复发独立增加了未来心血管疾病风险.
结论:
- GCA患者面临患心血管疾病的高风险,通常与低于最佳的脂质管理和不充分使用他类药物有关.
- 迫切需要加强预防策略,以减轻GCA人口中的心血管风险.
- 解决脂质异常并确保遵循指南的他类药物使用对于改善GCA患者的结果至关重要.
相关概念视频
01:30Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
01:30Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
01:26Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
01:23Rheumatic Heart Disease I: Introduction
16
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
16
01:30Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
01:26Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12